Notice: No offer or solicitation regarding securities

Contents are provided for general information purposes only and do not constitute an offer to sell or a solicitation of an offer to buy any security of Cloudbreak Pharma, Inc. (“Cloudbreak”) in any jurisdiction. Cloudbreak does not intend to solicit and is not soliciting, any action with respect to its security. Nothing in this website or the Contents thereof, individually or taken in the aggregate, constitutes an offer of securities for sale or a solicitation of an offer to buy any security in the United States, the United Kingdom, Hong Kong, Singapore, Japan, or in any other jurisdiction in which such an offer or solicitation is unlawful, or to US persons.

The Contents of this section have not been approved or disapproved by any securities commission or regulatory authority in Hong Kong or any other jurisdiction, and Cloudbreak expressly disclaims any duty to make disclosures or any filings with any securities commission or regulatory authority, beyond that imposed by applicable laws. The Contents of this section are neither sufficient nor intended by Cloudbreak to be used in connection with any decision relating to the purchase or sale of any existing or future Securities. Cloudbreak does not, does not intend to, and will not provide financial, investment, tax, legal, or accounting advice. Investors considering the purchase or sale of any Securities should consult with their own independent professional advisors.

The Contents of this section and the certain pages of the website contain information and documents that relate to securities that have not been registered, and will not be registered, for sale in the United States, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, or pledged in or delivered into the United States, or for the account or benefit of U.S. persons (as defined in Regulation S under the U.S. Securities Act of 1933 [the “Securities Act”], as amended) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. Such securities may also be subject to US tax law requirements. There will be no public offering of the Securities referred to in this section or any other page of the website in the United States. The Contents of this section, information contained in these pages, any opinion expressed therein and Other Contents of this website are provided solely for general information purposes, and do not constitute a sale of, offer for sale of, or solicitation of an offer to buy any securities in any jurisdiction.

Introduction

Individuals can invest in Cloudbreak Pharma, Inc. shares directly. Cloudbreak Pharma, Inc. is listed on the Hong Kong Stock Exchange (HKEX). The ticker symbol is 2592.

In the United States, there are multiple options to purchase securities listed on the Hong Kong stock exchange.  Some examples are below. 

Cloudbreak does not endorse any of these methods, which are being provided for informational purposes only.

ONLINE TRADING — INTERACTIVE BROKERS (IBKR)

Interactive Brokers, Inc. is a U.S.-based global brokerage platform that provides access to international markets, including the Hong Kong Stock Exchange.

Website: https://www.interactivebrokers.com/

OPENING AN ACCOUNT

To trade Hong Kong–listed shares through Interactive Brokers, investors must:

• Open and fund an approved IBKR account with full identity verification (KYC)

• Be approved for Asia / Hong Kong stock trading permissions based on investment experience, objectives, and financial profile

Search for “2592” once approved.

Note: A minimum of $2,000 USD (or equivalent) is required to trade on margin, sell short, or trade currencies or futures.

Estimated Fees:

Broker Commission:

• 0.08% of trade value

• Minimum HKD 18 ($2.31 USD) per order

Mandatory Local Fees:

• 0.13285% (consisting of Government stamp duty: 0.13%, SFC transaction levy: 0.0027%, and FRC transaction levy: 0.00015%)

PHONE TRADING — FIDELITY INVESTMENTS

Call the International Trading team at (800) 544-2976

M-F 5:00 am – 7:00 pm, ET

Sign up for Intl Trading. Features 25 markets, including HKEX.

Estimated Fees:

• HKD 250 per trade ($32.11 USD) (taxable accounts)

• HKD 83 per trade ($10.65 USD) (retirement accounts)

• 0.11% per trade (11 basis points)

• Additional 1% fee for trades under $100,000 USD

PHONE TRADING — CHARLES SCHWAB

Speak with a Schwab Global Investing Services specialist at 800-992-4685

5:30 p.m. ET Sunday and 5:30 p.m. ET Friday (24/5)

Trades are typically placed in 500-share increments.

Estimated Fees:

• 0.30% Schwab commission (30 basis points)

• $100 or 0.75% local exchange fees, whichever is greater